In Indonesia, stroke is the main cause of deaths in emergency room and major disability among middleage patients. The incidence rate of stroke is predicted higher in the future, along with increasing income and sedentary lifestyle.
Based on their pathology, stroke could be divided into hemorrhogic and ischemic stroke. Ischemic stroke need clot-dissolving agent, but the agent is a contraindication in hemorrhagic stroke (1,2).
Routine d ifferential diagnosis o f hemorrhagic from ischemic stroke i s performed b y Computed Tomography (CT) Scan and M agnetic Resonance Imaging (MRI). Both instruments not always available in all Indonesian health care facility (3, 4) .
Several neurospecific biomarkers for stroke have been studied. S100B P rotein, N SE and M BP concentrations a re elevated i n the blood of stroke patients, and correlated significantly with National Institutes of Health Stroke Scale (NIHSS) (5) . Heart-Type Fatty Acid Binding Protein (H-FABP) concentration is elevated in the blood of infarct and stroke patients (6) .
P atients and Methods

PATIENTS
In total o f 44 stroke adult patients consist o f 25 ischemic and 19 hemorrhagic strokes according to CTScan participated in this study. Written consent from subjects or patient's family received before subjects were enrolled in this study.
ASSAYS OF BIOCHEMICAL MARKERS Serum S100B Protein, NSE and MBP concentrations were m easured w ith Enzyme Linked Immuno Sorbent Assay kit from Syn X Pharma, Mississauga, CA. Serum H-FABP concentrations were measured with Enzyme Linked Immuno Sorbent Assay kit from Life Diagnostics, USA. Serum were separated from whole blood after centrifugation, and immediately kept at -20ºC until assays. All assays were performed according to manufacturers instruction.
For each run of s erum S100B P rotein, NSE and M BP, controls were included in the assays, and all results were within acceptable ranges. In our laboratory, the intraday imprecisions for all assays were lied between 4.2% -5.4%. STATISTICAL ANALYSIS All s tatistical calculations were performed u sing SPSS ver 11.5, SPSS Inc. Chicago. Parametric or nonparametric calculations w ere chosen whichever appropriate based on the normality of the data. ChiSquare analysis was used to determine association significance of two nominal data. T -test or MannWhitney U was used to compare means between two groups. ROC analysis was performed to determine cutoff point, and s ensitivity and s pecificity a t that point. Pearson or Spearman's Rho was used to determine correlation significance between two sets of data.
Results
All patients participated in this study are adults, men and women. There are not significant different of gender proportion (p=0.901) and time to onset (0.232) between ischemic and hemorrhagic group.
Among four stroke biochemical markers: S100B Protein, NSE, MBP and H-FABP in which serum samples obtained up to 72 hours after onset, only MBP showed a significant different in concentration between ischemic and hemorrhagic group, p=0.000.
The characteristics and serum biochemical marker concentrations of each group of all stroke patients are shown in table 1. Receiver Operating Characteristics (ROC) analysis showed that only area under curve of MBP (p=0.000) of up to 72 hours obtained samples significantly different from 0.5. But, if 24 hours samples obtained only, S100B Protein (p=0.030) and MBP (p=0.006) showed area under curved significantly different from 0.5.
Area under curve (AUC) of S100B Protein and MBP using serum samples obtained up to 72 hours and 24 hours are showed in Table 3 . Results showed that using serum samples obtained within 24 hours after onset, instead of up to 72 hours serum samples, improved performance of S100B Protein and MBP in differential diagnosis of hemorrhagic from ischemic stroke.
Further ROC analysis showed cutoff point, and sensitivity and specificity at the cutoff point. Table 4 showed cutoff point and its sensitivity and specificity for each marker in which the AUCs significantly differ from 0.5. The m ain purpose of t his research i s limited to find b iomarkers which a re c apable to d ifferentiate hemorrhagic from ischemic s troke. I n hemorrhagic stroke, patho-physiologically, there are more leucocytes especially Neutrofil and T-Cell infiltrate extravascular space of t he b rain c ompare w ith ischemic s troke. These inflammatory c ells a re r esponsible f or t he damage of neurons and/or glial cells through radical oxygen s pecies. M arkers of neurons and/or g lial cells damage w hich l eak i nto the circulation, c ould be detected in s erum o f the patients within hours after onset of the stroke. In the brain, glial cells are 50 times m ore prominent t han neuron cells, s o the rate limiting increase of biomarkers in the circulation is the Discussion number of leucocyte infiltrated. Markers of glial cells damage: S100B Protein and MBP would be higher in the circulation in hemorrhagic stroke c ompare w ith ischemic stroke, because leucocytes infiltration in the hemorrhagic stroke a re h igher t han ischemic s troke. On t he o ther hand, markers of neuron cells damage: NSE and H -FABP only slightly and not significantly increased i n hemorrhagic stroke c ompare w ith ischemic s troke, because the rate limiting increase of t he b iomarker i n the serum is t he number o f the damage c ells t heirsef. S chematic explanation of t he leak o f stroke b iomarkers into c irculation after onset of the stroke is represented in figure 1 and 2 . Only markers of glials cells damage in this study could be used for differential diagnosis of hemorrhagic stroke from ischemic stroke. Increased MBP concentration, from serum obtained within 24 hours after onset or up to 72 hours after onsert, is associated with hemorrhagic stroke. Increased S100B P rotein concentration is associated w ith hemorrhagic stroke only if serum could be obtained within 24 hours after onset of the stroke. After 24 hours, a rapid increased of S100B Protein in serum also occured in ischemic stroke. Figure 3 below figure out the rapid increased of S100B Protein after Ischemic Stroke (7) Further analysis indicated that using markers of glial cells damage: S100B Protein and MBP simultaneously could decreased missclasification from 5/22 (22.7%) to 4/22 (18.2%). Serum concentration of MBP equal or higher than 0,109 ng/ml and S100B Protein equal or higher than 7,55 pg/ml, both using serum obtained within 24 hours after onset of the stroke, are associated with hemorrhagic stroke.
Conclussion
MBP and S100B Protein are promising markers for differential diagnosis of hemorrhagic from ischemic stroke. Using serum samples obtained within 24 hours after onset and multiple markers (MBP and S100B Protein) will improve diagnostic performance of the test.
